Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,040,700 | 472,320 | 1,900,060 | 1,477,630 | 976,710 |
| Depreciation Amortization | 0 | 0 | 481,070 | 0 | 0 |
| Other Working Capital | -154,910 | 126,520 | -110,710 | -256,540 | -179,760 |
| Other Operating Activity | 349,880 | 127,060 | 263,590 | 730,020 | 460,110 |
| Operating Cash Flow | $1,235,670 | $725,900 | $2,534,010 | $1,951,110 | $1,257,060 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -177,410 | -72,270 | -345,530 | -199,980 | -113,820 |
| Other Investing Activity | -17,920 | -19,080 | 73,280 | -15,150 | -11,970 |
| Investing Cash Flow | $-195,330 | $-91,350 | $-272,250 | $-215,130 | $-125,790 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | 0 | -550,610 | 0 | 0 |
| Other Financing Activity | -1,072,890 | -785,400 | -901,280 | -1,246,740 | -888,930 |
| Financing Cash Flow | $-1,072,890 | $-785,400 | $-1,451,890 | $-1,246,740 | $-888,930 |
| Exchange Rate Effect | 4,200 | 1,750 | -390 | -800 | 2,940 |
| Beginning Cash Position | 1,595,980 | 1,527,050 | 909,540 | 932,630 | 969,570 |
| End Cash Position | 1,567,630 | 1,377,950 | 1,719,020 | 1,421,070 | 1,214,850 |
| Net Cash Flow | $-28,340 | $-149,100 | $809,470 | $488,430 | $245,280 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,235,670 | 725,900 | 2,534,010 | 1,951,110 | 1,257,060 |
| Free Cash Flow | 1,235,670 | 725,900 | 2,534,010 | 1,951,110 | 1,257,060 |